Cite
HARVARD Citation
Entrena, A. et al. (2015). Mesenchymal stem cells derived from low risk acute lymphoblastic leukemia patients promote NK cell antitumor activity. Cancer letters. 363 (2), pp. 156-165. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Entrena, A. et al. (2015). Mesenchymal stem cells derived from low risk acute lymphoblastic leukemia patients promote NK cell antitumor activity. Cancer letters. 363 (2), pp. 156-165. [Online].